CN Patent
CN109071512A — 作为激酶抑制剂的含磷化合物
Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2018-12-21 · 7y expired
What this patent protects
本发明涉及一类ALK抑制剂、及其药物组合物和使用方法。
USPTO Abstract
本发明涉及一类ALK抑制剂、及其药物组合物和使用方法。
Drugs covered by this patent
- Alunbrig (brigatinib) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.